Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. The company is headquartered in Settsu-Shi, Osaka-Fu and currently employs 39,168 full-time employees. The company has three segments. The Medical segment consists of the domestic business division and the international business division. The domestic business division sells medical devices related to injections and infusions, artificial organs, high-performance medicines, and dialysis. The international business division, centered on the head office, has medical device manufacturing and sales bases overseas for regional expansion, selling medical devices related to injections and infusions, artificial organs, and diabetes. The Pharmaceutical segment sells pharmaceuticals related to kit preparation containers on a contract basis from pharmaceutical companies. The Pharma Packaging segment sells medical glass products such as glass tubes and ampoules, thermos flasks, and kit preparation containers in Japan.
Son mali tabloya (Form-10K) göre, Anton Oilfield Services Group'in toplam varlıkları $0 olup, net 損失 $0'dir.
NPRRF'ün temel finansal oranları nelerdir?
Anton Oilfield Services Group'in cari oranı 0, net kâr marjı 0, hisse başına satış $0'dir.
Nipro Corp'in geliri segment veya coğrafya bazında nasıl dağılıyor?
Anton Oilfield Services Group の最大収益セグメントは Oilfield Technical Services で、最新の利益発表における収益は 2,304,991,682 です。地域別に見ると、Iraq が Anton Oilfield Services Group の主要市場であり、収益は 2,820,487,014 です。
Nipro Corp kârlı mı?
いいえ, son mali tablolara göre Anton Oilfield Services Group'in net 損失 $0'dir.
Nipro Corp'in herhangi bir yükümlülüğü var mı?
いいえ, Anton Oilfield Services Group'in yükümlülüğü 0'dir.
Nipro Corp'in tedavüldeki hisse sayısı kaçtır?
Anton Oilfield Services Group'in toplam tedavüldeki hisse sayısı 0'dir.